English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Apr 27, 2022 16:09 HKT
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022
Apr 26, 2022 18:07 HKT
君联资本联合创建企业朗信生物遗传性视网膜变性基因治疗产品在中国获批临床
Apr 24, 2022 17:02 HKT
君聯資本聯合創建企業朗信生物遺傳性視網膜變性基因治療產品在中國獲批臨床
Apr 24, 2022 17:01 HKT
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Apr 24, 2022 17:00 HKT
医思健康料全年销售额超30亿港元 按年增逾35%
Apr 21, 2022 09:09 HKT
醫思健康料全年銷售額超30億港元 按年增逾35%
Apr 21, 2022 09:08 HKT
EC Healthcare expects sales volume to increase 35% Y-o-Y to no less than HK$3 billion for the Year
Apr 21, 2022 09:07 HKT
中国抗体公布SN1011新药研究申请获国家药监局批准
Apr 20, 2022 19:35 HKT
中國抗體公佈SN1011新藥研究申請獲國家藥監局批准
Apr 20, 2022 19:34 HKT
SinoMab Announces IND APPLICATION FOR SN1011 APPROVED BY NMPA
Apr 20, 2022 19:33 HKT
아방스 클리니컬, 인포마파마인텔리전스 어워드 2022에서 아태지역 최고CRO상 최종 후보로 선정
Apr 20, 2022 16:00 HKT
Actual net profit exceeds FY2020's level, China Biotech Services' (08037) new growth drivers expected to erupt consecutively
Apr 20, 2022 11:29 HKT
Avance Clinical進入Informa Pharma Intelligence 2022年亞太地區最佳CRO最終候選名單
Apr 19, 2022 10:02 HKT
Avance Clinical进入Informa Pharma Intelligence 2022年亚太地区最佳CRO最终候选名单
Apr 19, 2022 10:01 HKT
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC
Apr 19, 2022 10:00 HKT
珠海金明獲百年老品牌余仁生保嬰丹代理權
Apr 07, 2022 20:31 HKT
医思健康收购兽医业务 进一步整合宠物服务市场 提升市场占有率
Apr 07, 2022 09:17 HKT
醫思健康收購獸醫業務 進一步整合寵物服務市場 提升市場佔有率
Apr 07, 2022 09:16 HKT
EC Healthcare Acquires Veterinary Business, Further Consolidate the Pet Service Industry and Increase Market Shares
Apr 07, 2022 09:15 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: